Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Omeros Corp (OMER)

Omeros Corp (OMER)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 195,718
  • Shares Outstanding, K 62,730
  • Annual Sales, $ 0 K
  • Annual Income, $ 194,240 K
  • 60-Month Beta 0.82
  • Price/Sales 2.45
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OMER with:

Options Overview Details

View History
  • Implied Volatility 129.05% ( -16.08%)
  • Historical Volatility 84.44%
  • IV Percentile 81%
  • IV Rank 54.34%
  • IV High 195.36% on 05/09/22
  • IV Low 50.14% on 08/12/21
  • Put/Call Vol Ratio 3.80
  • Today's Volume 394
  • Volume Avg (30-Day) 446
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 47,710
  • Open Int (30-Day) 43,734

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.64
  • Number of Estimates 1
  • High Estimate -0.64
  • Low Estimate -0.64
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.50 +17.20%
on 05/12/22
4.78 -38.70%
on 04/19/22
-1.76 (-37.53%)
since 04/18/22
3-Month
2.50 +17.20%
on 05/12/22
7.45 -60.70%
on 03/01/22
-4.16 (-58.67%)
since 02/18/22
52-Week
2.50 +17.20%
on 05/12/22
17.65 -83.39%
on 05/19/21
-14.86 (-83.53%)
since 05/18/21

Most Recent Stories

More News
Omeros Corporation Reports First Quarter 2022 Financial Results

Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as...

OMER : 2.93 (-6.09%)
Omeros Corporation to Announce First Quarter Financial Results on May 10, 2022

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2022, on Tuesday, May 10, 2022, after the market closes....

OMER : 2.93 (-6.09%)
Omeros Announces Journal of Clinical Oncology Publication Detailing Pivotal Trial Results for Narsoplimab in HSCT-TMA

Omeros Corporation (Nasdaq: OMER) today announced the online publication of a manuscript detailing the results of its pivotal study assessing efficacy and safety of narsoplimab for the treatment of hematopoietic...

OMER : 2.93 (-6.09%)
Omeros Becomes Oversold (OMER)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

OMER : 2.93 (-6.09%)
Why Earnings Season Could Be Great for Omeros (OMER)

Omeros (OMER) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

OMER : 2.93 (-6.09%)
Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 1, 2022

Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2021, on Tuesday, March 1, 2022, after...

OMER : 2.93 (-6.09%)
RSI Alert: Omeros Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

OMER : 2.93 (-6.09%)
Omeros Confirms Submission of Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA

Omeros Corporation (Nasdaq: OMER) today confirmed that earlier this month the company submitted to the U.S. Food and Drug Administration (FDA) its response to the Agency’s Complete Response Letter (CRL)...

OMER : 2.93 (-6.09%)
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical

Omeros Corporation (Nasdaq: OMER) today announced that it has completed the sale of OMIDRIA (phenylephrine and ketorolac intraocular solution) 1.0%/0.3% to Rayner Surgical Group Inc . , an affiliate of...

OMER : 2.93 (-6.09%)
Do Options Traders Know Something About Omeros (OMER) Stock We Don't?

Investors need to pay close attention to Omeros (OMER) stock based on the movements in the options market lately.

OMER : 2.93 (-6.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM)...

See More

Key Turning Points

3rd Resistance Point 3.24
2nd Resistance Point 3.16
1st Resistance Point 3.05
Last Price 2.93
1st Support Level 2.85
2nd Support Level 2.77
3rd Support Level 2.66

See More

52-Week High 17.65
Fibonacci 61.8% 11.86
Fibonacci 50% 10.07
Fibonacci 38.2% 8.29
Last Price 2.93
52-Week Low 2.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar